Clinical Trial Update: Trial Comparing the Safety of Two Different Intravenous Iron Formulations [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing the safety of two intravenous iron formulations has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Intravenous iron formulation A
• Intravenous iron formulation B

Snippet

Sponsor: London Health Sciences Centre | Conditions: Iron Deficiency Anemia, Perioperative Blood Conservation | Phase 4 | Status: SUSPENDED